Package 59676-572-01

{"route": ["ORAL"], "spl_id": "02fc6f4f-330d-b32e-e063-6294a90a028a", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000185504", "N0000182140", "N0000185503"], "upc": ["0359676570011", "0359676571018", "0359676572015"], "unii": ["0C50HW4FO1"], "rxcui": ["754761", "758555", "1052658", "1052660", "1250721", "1250723"], "spl_set_id": ["6a9cbc29-9f15-4b24-8d86-206b82887f3d"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Janssen Products LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE, PLASTIC (59676-572-01)", "package_ndc": "59676-572-01", "marketing_start_date": "20120326"}], "brand_name": "Intelence", "product_id": "59676-572_02fc6f4f-330d-b32e-e063-6294a90a028a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "59676-572", "generic_name": "etravirine", "labeler_name": "Janssen Products LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Intelence", "active_ingredients": [{"name": "ETRAVIRINE", "strength": "25 mg/1"}], "application_number": "NDA022187", "marketing_category": "NDA", "marketing_start_date": "20120326", "listing_expiration_date": "20261231"}